Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.47 |
| ▸ | PEPD | P12955 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18590666 | 1.00 | BTK (0.47) | BTKPEPDACEHSD17B10MEN1 | |
| SCHEMBL15023147 | 1.00 | BTK (0.47) | BTKPEPDACEHSD17B10MEN1 | |
| SCHEMBL1296980 | 0.96 | BTK (0.44) | BTKPEPD | |
| SCHEMBL20405088 | 0.92 | BTK (0.46) | BTKHSD17B10MAPK1 | |
| Ethylene Glycol SCHEMBL1296627 | 0.89 | BTK (0.40) | BTKPEPD | |
| SCHEMBL1297246 | 0.89 | BTK (0.45) | BTKPEPDACEHSD17B10MEN1 | |
| SCHEMBL1296115 | 0.87 | EPHX1 (0.41) | BTKHSD17B10MAPK1 | |
| SCHEMBL1297250 | 0.86 | BTK (0.42) | BTKPEPDACEHSD17B10MAPK1 | |
| SCHEMBL8140944 | 0.84 | CHRM2 (0.43) | BTK | |
| SCHEMBL8181924 | 0.84 | CHRM2 (0.43) | BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023176867-A1 | METHOD FOR PRODUCING 2-ACETYL-1-PYRROLINE | 日清食品ホールディングス株式会社 | 2023-09-21 | — | — | WO | disclosed |
| CN-111777477-B | Method for synthesizing succinic acid derivative or 3-aryl propionic acid | 四川大学 | 2021-09-14 | — | — | CN | disclosed |
| US-20210053981-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2021-02-25 | — | — | US | disclosed |
| CN-111777477-A | Method for synthesizing succinic acid derivative or 3-aryl propionic acid | 四川大学 | 2020-10-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210053981-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SARS1 | BTK 3709/4885PEPD 1017/4885ACE 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.